Clearnote Health
Gulfem D. Guler has worked for four companies since 2005. Gulfem D. began as a Research Assistant / Graduate Student at Vanderbilt University in 2005 and then became a Postdoctoral Research Fellow at Genentech in 2012. In 2016, they moved to Celgene and served as a Scientist I and Scientist II. Most recently, in 2018, they joined Bluestar Genomics, Inc - Precision Epigenomic Medicine as a Senior Scientist and Director.
Gulfem D. Guler completed their B.S. in Biological Sciences and Bioengineering from Sabanci University in 2005. Gulfem D. then went on to earn their Ph.D. in Biological Sciences from Vanderbilt University in 2011.
This person is not in any offices
Clearnote Health
ClearNote Health (formerly Bluestar Genomics) – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. They focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. They apply their proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops. With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally.